Mark Berger
Patrimonio netto: 2 025 $ in data 31/07/2026
Patrimonio netto: 2 025 $ in data 31/07/2026
Mark S.
Berger is currently Chief Medical Officer at Genprex, Inc. since 2021.
Former positions include Senior Director-Oncology Clinical Development at Wyeth Pharmaceuticals LLC; Group Director-Clinical Oncology at GSK Plc from 2002 to 2007; Principal at the University of Pennsylvania; Vice President-Clinical Development at Gemin X Pharmaceuticals US, Inc. from 2007 to 2011; Chief Medical Officer at Deciphera Pharmaceuticals LLC from 2011 to 2013; Senior Vice President-Clinical Research at Kadmon Corp.
LLC from 2013 to 2017; and Chief Medical Officer at Actinium Pharmaceuticals, Inc. from 2017 to 2021.
Education includes undergraduate studies at Wesleyan University and a doctorate from The University of Virginia School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GENPREX INC 0,07% | 15/04/2026 | 338 ( 0,07% ) | 2 025 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GENPREX, INC. | Direttore Tecnico/Scientifico/R&S | 27/09/2021 |
| Società | Posizione | Fine |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 24/09/2021 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Direttore Tecnico/Scientifico/R&S | 01/09/2013 |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Corporate Officer/Principal | 01/06/2011 |
| GSK PLC | Corporate Officer/Principal | 01/02/2007 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Genprex, Inc.
Genprex, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular therapies for cancer treatment | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Health Technology |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The University of Virginia School of Medicine
The University of Virginia School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale